Sale!

Leukeran (Chlorambucil)

A$73.44

-52%
Leukeran (chlorambucil) is a cancer medicine used to treat certain blood cancers, such as chronic lymphocytic leukaemia (CLL) and some types of lymphoma. It works by slowing the growth of cancer cells. Treatment may be given in cycles, and your doctor will monitor you closely. Common side effects can include tiredness, nausea, reduced blood counts, and increased infection risk. If you feel unwell or notice infections, contact your healthcare team promptly.

Leukeran (Chlorambucil) – Patient Guide (Australia)

Leukeran is a cancer medicine containing chlorambucil. It belongs to a group of medicines called alkylating agents, which work by damaging the DNA of rapidly dividing cells. Leukeran may be used in certain blood-related cancers and related conditions, typically when other treatment options are not suitable.

This guide is written to be patient-friendly and practical. It explains what Leukeran is, how it works, how it is used, common safety concerns, and what to discuss with your healthcare team.


Basic product information

Feature Information
Brand name Leukeran
Active ingredient Chlorambucil
Medicine type Chemotherapy / alkylating agent (anticancer medicine)
Common dosage form Tablet (oral)
Typical use setting Haematology/oncology care
Availability in Australia Medicine may be supplied under appropriate clinical arrangements

Availability, brand presentation, and pack sizes can vary. If you are unsure what you will receive, ask your pharmacist to confirm the strength and tablet appearance.


How Leukeran works (mechanism of action)

Chlorambucil is an alkylating agent. Once in the body, it is converted into reactive compounds that attach (alkylate) to DNA. This causes DNA damage and interferes with the ability of cancer cells to grow and divide.

Because cancer cells often divide more rapidly than normal cells, they are generally more affected by DNA damage. However, some normal blood-forming cells can also be affected, which is why blood tests and monitoring are important.


Pharmacokinetics (how the body handles chlorambucil)

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. While exact values can vary by patient, the following features are typical for chlorambucil:

  • Absorption: Taken by mouth; absorption occurs after swallowing the tablet.
  • Metabolism: Chlorambucil is metabolised mainly in the liver.
  • Active effect: The medicine’s anticancer effect relates to DNA damage produced by the drug’s reactive metabolites.
  • Elimination: Metabolites are eliminated predominantly through the kidneys and via bile.
  • Duration: Clinical effects may continue beyond a single dose because of how cancer cells respond to DNA damage over time.

Your healthcare team may adjust dosing schedules depending on how your body tolerates treatment and the results of blood tests and liver function tests.


Typical uses and indications

Leukeran (chlorambucil) is used for certain cancer and blood disorders. Indications may differ depending on clinical criteria and local treatment protocols. Common indications include:

  • Chronic lymphocytic leukaemia (CLL)
  • Some forms of non-Hodgkin lymphoma, including certain low-grade or indolent lymphomas where appropriate
  • Other haematological malignancies in specific clinical situations

Your treating team will determine whether Leukeran is suitable based on diagnosis, disease stage, prior treatments, general health, and blood counts.


How long it takes to work (timing)

Cancer medicines work on a cell-cycle and DNA-damage basis, so improvement may take time. Timing can vary widely from person to person. You might notice:

  • Early signs: Some people may feel more stable energy levels or reduced symptoms within weeks.
  • Test results: Blood counts and tumour response assessments are typically evaluated over several weeks to months.
  • Monitoring: Ongoing blood tests help confirm your body is tolerating treatment.

If you are concerned about how fast treatment is working, ask your clinician what milestones they expect and when the next assessment will occur.


Dosing overview (what patients should know)

Dosing is individualised and depends on factors such as the specific condition being treated, your blood counts, liver function, age, and treatment goals. Do not change your dose or schedule without medical advice.

Because dosing regimens may vary (for example, daily schedules or intermittent schedules depending on the indication), the most accurate dosing information is the plan provided by your healthcare team.

  • Tablets are usually taken by mouth with or without food, according to your schedule and tolerance.
  • Consistency matters: Try to take doses at about the same time each day if using a daily regimen.
  • Missed dose: If you miss a dose, contact your pharmacist or clinic for advice rather than doubling up.
  • Blood count monitoring: Dose adjustments may be needed if white blood cells or platelets fall.

If you need help planning your routine (timing with other medications, meals, or managing side effects), your pharmacist can assist.


Food interactions and taking with meals

Food interactions can influence tolerability more than the medicine itself. In general:

  • Take with or without food if your clinician/pharmacist has not specified otherwise.
  • If you get nausea, taking the tablet with a light meal may reduce discomfort for some people.
  • Stay hydrated and follow any dietary advice from your care team, especially if you experience reduced appetite.

If you have specific dietary restrictions or have been advised about liver disease or other conditions, discuss how to take your medicine in your particular situation.


Alcohol and medicine interactions

Alcohol can affect the liver and may worsen fatigue, nausea, or dehydration—factors that may be relevant during cancer treatment. Because chlorambucil is metabolised in the liver, it’s generally advisable to avoid alcohol or keep it to a minimum, unless your clinician says otherwise.

General safety points

  • Avoid binge drinking.
  • Ask about compatibility if you take regular medications such as anti-nausea medicines, antibiotics, antifungals, or anticoagulants.
  • Watch for side effects such as dizziness, sleepiness, unusual bruising, or infection symptoms—seek advice promptly if these occur.

Always tell your healthcare team about all medicines and supplements you use (including herbal products and vitamins). Interactions can occur, particularly with medicines that affect liver enzymes or bone marrow function.


Safety profile: what to watch for

Leukeran can cause side effects, most importantly affecting bone marrow, which produces blood cells. Your healthcare team monitors blood counts closely.

Common and important side effects

  • Low white blood cells (neutropenia/leukopenia): increases infection risk.
  • Low platelets (thrombocytopenia): may lead to easier bruising or bleeding.
  • Anaemia: may cause tiredness, breathlessness, or weakness.
  • Nausea and vomiting: may occur in some people.
  • Loss of appetite and fatigue.
  • Hair thinning (may be less frequent than with some other chemotherapy agents, but can occur).
  • Temporary liver test changes in some patients.

Serious symptoms—seek urgent medical advice

Contact your healthcare team promptly (or seek urgent care according to your local advice) if you develop:

  • Fever or signs of infection (chills, sore throat, cough, burning urine)
  • Unusual bleeding (nosebleeds, bleeding gums, blood in urine or stool)
  • Severe or persistent vomiting or inability to keep fluids down
  • Severe fatigue, dizziness, or shortness of breath
  • Rash that is severe or accompanied by blistering or facial swelling

Long-term considerations

Alkylating agents can be associated with a small increased risk of secondary cancers in some settings. Your clinician will weigh benefits versus risks for your specific diagnosis and treatment history.


Practical use tips for patients

  • Follow the schedule exactly: Leukeran regimens are structured; missing doses or changing timing may affect results.
  • Keep track: Use a medication organiser or calendar reminders.
  • Attend blood tests: These guide treatment safety and may lead to dose adjustments.
  • Infection prevention: Practise good hand hygiene, avoid close contact with people who have contagious illnesses, and ask about whether you should avoid crowds during low white blood cell periods.
  • Bleeding precautions: Use a soft toothbrush, avoid unnecessary trauma, and avoid non-prescribed aspirin/NSAIDs unless approved.
  • Hydration and nutrition: Small frequent meals may be easier if you have nausea or reduced appetite.
  • Contraception and pregnancy planning: Discuss fertility and contraception with your clinician before starting. If pregnancy is possible, use reliable contraception as advised.
  • Handling tablets: Tablets should be handled carefully. If someone else assists you, they should wear gloves if instructed, and avoid crushing or splitting tablets unless your pharmacist advises.

Alternative options (discussion points)

Treatment choices for CLL and certain lymphomas can include targeted therapies, immunotherapies, and other chemotherapy options. Alternatives depend on your specific diagnosis, genetic markers, disease burden, prior treatments, and overall health.

Possible alternative approaches (examples)

  • Targeted medicines (e.g., kinase inhibitors) for some patients with CLL
  • Monoclonal antibody therapy in combination regimens for certain lymphomas or CLL scenarios
  • Other chemotherapy agents with different side-effect profiles
  • Watchful waiting / active surveillance in early-stage, low-burden CLL where appropriate

Ask your clinician to explain why Leukeran was selected in your situation and what alternatives were considered, including how side effects and monitoring differ.


Market and legal context for Australia

Medicines in Australia are regulated by the Therapeutic Goods Administration (TGA). Many cancer medicines are supplied through structured pathways that involve prescribers, cancer services, and pharmacy dispensing systems. Supply may be subject to clinical appropriateness, stock availability, and safety requirements.

For patients, this generally means:

  • Your medicine is provided with appropriate information about safe use and monitoring.
  • Some medicines may require coordination with oncology services or specialist clinics.
  • Pharmacies may need to verify details such as formulation strength and treatment schedule before dispensing.

Your pharmacist can also advise on practical aspects of obtaining your medicine reliably, including expected delivery times and what to do if you are running low.


Recent guidance and monitoring (Australia-focused)

Guidance in cancer care evolves as new evidence becomes available. In Australia, decisions are commonly supported by:

  • National and state cancer management pathways
  • Specialist consensus and clinical guidelines for haematologic cancers
  • Local hospital protocols for blood monitoring, dose modifications, and supportive care

For Leukeran specifically, the key ongoing safety emphasis is typically on:

  • Regular blood tests to monitor white blood cell and platelet counts
  • Infection and bleeding precautions during periods of low counts
  • Assessment of liver function when indicated
  • Clear patient education on when to contact the clinic urgently

If you’re unsure whether your monitoring schedule aligns with current local practice, ask your treating team to review it with you.


Delivery, availability, and how to plan ahead

Availability can vary depending on supply chains and which presentation/strength your treatment plan requires. Many pharmacies can provide:

  • Home delivery (where available) with tracking
  • Consolidated dispensing strategies to reduce the risk of running out
  • Packaging suited to safe storage and clear labelling

Practical tip: Plan ahead for refills. Because treatment schedules and blood test results may lead to dose adjustments, it can be helpful to arrange delivery timing to avoid delays between visits and dispensing.

If your medicine is urgent (for example, you are due to start a new cycle), contact the pharmacy as early as possible so they can check stock and confirm dispatch timelines.


How to store Leukeran

  • Store as directed on the packaging.
  • Keep out of sight and reach of children.
  • Protect from moisture and heat according to the label instructions.

If your tablets look different from what you expect (e.g., discoloured, damaged packaging), do not use them—contact your pharmacist.


FAQ

Is Leukeran taken once a day or multiple times?

Schedules vary by condition and treatment plan. Some regimens involve daily dosing for a period, while others may be intermittent. Always follow the timetable provided by your healthcare team.

What blood tests will I need?

Typically, doctors monitor full blood counts (white cells, haemoglobin, platelets) and may also check liver function. The exact frequency depends on your situation and how you respond.

Can I drive while taking Leukeran?

Many people can drive, but if you experience fatigue, dizziness, or feel unwell, avoid driving and seek advice. Also consider any other medicines you take (for nausea, pain, or allergies) which may affect alertness.

What should I do if I feel very tired?

Fatigue is common during cancer treatment and can also be linked to anaemia or infection. Contact your clinician if fatigue is severe, worsening, or associated with shortness of breath, fever, or bleeding/bruising.

How can I reduce my risk of infection?

Practical steps include good hand hygiene, avoiding sick contacts, and following your clinic’s advice about when to seek urgent help. If your white blood cell count is low, your team may give specific precautions or preventive strategies.

Are there foods I must avoid?

There are no universal “must avoid” foods for chlorambucil for most patients, but nausea and appetite changes may influence what is comfortable to eat. If you have additional dietary restrictions due to other health conditions, follow those recommendations.

Can I drink alcohol while on Leukeran?

It’s generally best to avoid alcohol or keep it minimal, particularly because chlorambucil is processed in the liver. Your clinician can provide a personalised recommendation based on your health and other medicines.

What other medicines can interact with Leukeran?

Interactions depend on what else you take. Tell your pharmacist and clinician about all medicines, including over-the-counter products and supplements. Some medicines that affect the liver or bone marrow, or that increase bleeding risk, may require extra caution.

What if I miss a dose?

If you miss a dose, do not automatically double up. Contact your pharmacist or oncology clinic for advice based on your treatment schedule.

Is Leukeran used for children?

Use in paediatric populations depends on diagnosis, specialist recommendations, and suitability based on risk/benefit. Discuss any questions with your child’s treating team.

When should I seek urgent help?

Seek urgent medical advice if you develop fever or signs of infection, unusual bleeding, severe vomiting, or other symptoms your clinic has previously highlighted for immediate attention.


Before you start: important discussion checklist

  • Confirm your dosing schedule and what to do if you miss a dose.
  • Ask when your next blood test is due.
  • Review symptoms that require urgent contact (fever, bleeding, infection signs).
  • Discuss pregnancy prevention and family planning (if relevant).
  • Review your current medication list, including OTC medicines and supplements.
  • Plan transport and support for days when side effects may make you feel unwell.

If you have any concerns about how Leukeran should be taken or how to manage side effects, your pharmacist is a great first point of contact. They can also help you understand safe storage and coordination for delivery and refills across treatment cycles.

Additional information

Dosage: No selection

2mg, 5mg

Package: No selection

30 pill, 60 pill, 90 pill